logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9199959 B1

PDFFull Text
Date of Patent:
Dec. 01, 2015

Filed:

Oct. 25, 2012

Hiv replication inhibitor

Applicant:

Shionogi & Co., Ltd., Osaka-shi, JP;

Inventors:

Tsutomu Iwaki, Toyonaka, JP;

Kenji Tomita, Toyonaka, JP;

Assignee:

SHIONOGI & CO., LTD., Osaka-shi, JP;

Attorney:

Oblon, McClelland, Maier & Neustadt, L.L.P.

Primary Examiner:

Nizal Chandrakumar

Int. Cl.
CPC ...
C07C 69/74 (2006.01); C07D 311/58 (2006.01); C07C 275/42 (2006.01); C07C 205/56 (2006.01); C07C 311/14 (2006.01); C07C 233/63 (2006.01); C07C 233/81 (2006.01); C07C 255/59 (2006.01); C07C 271/28 (2006.01); C07C 311/10 (2006.01); C07C 311/21 (2006.01); C07C 317/48 (2006.01); C07C 229/42 (2006.01); C07C 233/54 (2006.01); C07D 405/14 (2006.01); C07D 215/14 (2006.01); C07D 215/227 (2006.01); C07D 311/74 (2006.01); C07D 317/60 (2006.01); C07D 319/12 (2006.01); C07D 319/16 (2006.01); C07D 235/26 (2006.01); C07D 405/04 (2006.01); C07D 405/10 (2006.01); C07D 405/12 (2006.01); C07D 407/12 (2006.01); C07D 409/12 (2006.01); C07D 413/10 (2006.01); C07D 413/12 (2006.01); C07D 491/06 (2006.01); C07D 265/36 (2006.01); C07D 277/82 (2006.01); C07D 307/79 (2006.01); C07D 307/83 (2006.01); C07D 307/88 (2006.01); C07D 307/89 (2006.01); C07D 319/18 (2006.01); C07D 319/20 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 311/58 (2013.01); C07C 205/56 (2013.01); C07C 229/42 (2013.01); C07C 233/54 (2013.01); C07C 233/63 (2013.01); C07C 233/81 (2013.01); C07C 255/59 (2013.01); C07C 271/28 (2013.01); C07C 275/42 (2013.01); C07C 311/10 (2013.01); C07C 311/14 (2013.01); C07C 311/21 (2013.01); C07C 317/48 (2013.01); C07D 215/14 (2013.01); C07D 215/227 (2013.01); C07D 235/26 (2013.01); C07D 265/36 (2013.01); C07D 277/82 (2013.01); C07D 307/79 (2013.01); C07D 307/83 (2013.01); C07D 307/88 (2013.01); C07D 307/89 (2013.01); C07D 311/74 (2013.01); C07D 317/60 (2013.01); C07D 319/12 (2013.01); C07D 319/16 (2013.01); C07D 319/18 (2013.01); C07D 319/20 (2013.01); C07D 405/04 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/12 (2013.01); C07D 409/12 (2013.01); C07D 413/10 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 491/06 (2013.01); C07C 2101/02 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01); C07C 2101/16 (2013.01); C07C 2101/18 (2013.01);
Abstract

The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent. wherein, a broken line means the presence or absence of a bond; Ris substituted or unsubstituted alkyl etc., Ris substituted or unsubstituted alkyloxy etc.; n isor; Ris a substituted or unsubstituted aromatic carbocyclic group; Ris a hydrogen atom etc.; Ris a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; Ris substituted or unsubstituted alkyl; Ris —Z—Retc.; Z is —NR—CO— etc.; Ris substituted or unsubstituted alkyl etc.; Ris a hydrogen atom etc.

Find Patent Forward Citations

Loading…